281 related articles for article (PubMed ID: 16941369)
1. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
Meylan PR; Pascual M
Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369
[No Abstract] [Full Text] [Related]
2. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients.
Singh N
Clin Infect Dis; 2001 Mar; 32(5):742-51. PubMed ID: 11229841
[TBL] [Abstract][Full Text] [Related]
3. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: a meta-analysis comparing prophylactic and preemptive therapies.
Small LN; Lau J; Snydman DR
Clin Infect Dis; 2006 Oct; 43(7):869-80. PubMed ID: 16941368
[TBL] [Abstract][Full Text] [Related]
4. Preemptive treatment for cytomegalovirus viremia to prevent cytomegalovirus disease in solid organ transplant recipients.
Strippoli GF; Hodson EM; Jones C; Craig JC
Transplantation; 2006 Jan; 81(2):139-45. PubMed ID: 16436954
[TBL] [Abstract][Full Text] [Related]
5. Prevention and management of cytomegalovirus infection in solid-organ transplantation.
Mwintshi K; Brennan DC
Expert Rev Anti Infect Ther; 2007 Apr; 5(2):295-304. PubMed ID: 17402844
[TBL] [Abstract][Full Text] [Related]
6. Prophylaxis and treatment of cytomegalovirus disease in recipients of solid organ transplants: current approach and future challenges.
Puius YA; Snydman DR
Curr Opin Infect Dis; 2007 Aug; 20(4):419-24. PubMed ID: 17609603
[TBL] [Abstract][Full Text] [Related]
7. Infection in solid-organ transplant recipients.
Fishman JA
N Engl J Med; 2007 Dec; 357(25):2601-14. PubMed ID: 18094380
[No Abstract] [Full Text] [Related]
8. Cytomegalovirus infection in organ transplant recipients.
Hibberd PL; Snydman DR
Infect Dis Clin North Am; 1995 Dec; 9(4):863-77. PubMed ID: 8747770
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infection in solid organ transplant recipients: new challenges and their implications for preventive strategies.
Singh N
J Clin Virol; 2006 Apr; 35(4):474-7. PubMed ID: 16406798
[TBL] [Abstract][Full Text] [Related]
10. Oral ganciclovir usage for cytomegalovirus prophylaxis in organ transplant recipients: is emergence of resistance imminent?
Singh N; Yu VL
Dig Dis Sci; 1998 Jun; 43(6):1190-2. PubMed ID: 9635606
[No Abstract] [Full Text] [Related]
11. Late-onset cytomegalovirus disease as a significant complication in solid organ transplant recipients receiving antiviral prophylaxis: a call to heed the mounting evidence.
Singh N
Clin Infect Dis; 2005 Mar; 40(5):704-8. PubMed ID: 15714416
[No Abstract] [Full Text] [Related]
12. Current status and impact of CMV prevention following pediatric organ transplantation.
Allen UD
Pediatr Transplant; 2008 Jun; 12(4):389-92. PubMed ID: 18466425
[No Abstract] [Full Text] [Related]
13. Management of cytomegalovirus infection and disease after solid-organ transplantation.
van der Bij W; Speich R
Clin Infect Dis; 2001 Jul; 33 Suppl 1():S32-7. PubMed ID: 11389520
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
Fisher RA
Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
[TBL] [Abstract][Full Text] [Related]
15. Delayed occurrence of cytomegalovirus disease in organ transplant recipients receiving antiviral prophylaxis: are we winning the battle only to lose the war?
Singh N
Eur J Clin Microbiol Infect Dis; 2002 Sep; 21(9):643-6. PubMed ID: 12373496
[No Abstract] [Full Text] [Related]
16. Prevention of cytomegalovirus following solid organ transplantation: a literature review.
Kowalsky S; Arnon R; Posada R
Pediatr Transplant; 2013 Sep; 17(6):499-509. PubMed ID: 23890075
[TBL] [Abstract][Full Text] [Related]
17. Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.
Hodson EM; Jones CA; Webster AC; Strippoli GF; Barclay PG; Kable K; Vimalachandra D; Craig JC
Lancet; 2005 Jun 18-24; 365(9477):2105-15. PubMed ID: 15964447
[TBL] [Abstract][Full Text] [Related]
18. Preemptive therapy for cytomegalovirus infections and the development of resistance to ganciclovir.
Kroes AC; Kalpoe JS
J Infect Dis; 2002 Sep; 186(5):724-5; author reply 725-6. PubMed ID: 12195366
[No Abstract] [Full Text] [Related]
19. Counterpoint: prevention of cytomegalovirus (CMV) infection and CMV disease in recipients of solid organ transplants: the case for prophylaxis.
Snydman DR
Clin Infect Dis; 2005 Mar; 40(5):709-12. PubMed ID: 15714417
[No Abstract] [Full Text] [Related]
20. Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus.
Avery RK
Clin Infect Dis; 2007 Aug; 45(4):448-9. PubMed ID: 17638192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
